A Cancer Revolution
Revolution Medicines' share price has been volatile in the short term but strong over longer periods. See what analysts think Revolution Medicines's shares could be worth. Find out about the key risks to this Revolution Medicine narrative. See why 17 investors see the company as 27% undervalued.